Some users may experience side effects such as nausea, fatigue, or gastrointestinal discomfort, especially when starting GLP-1 medications or oral kits
Lingvay I, Catarig AM, Frias JP (2019) Efficacy and safety of once weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
Babu B, Avinash M (2012) Melanotic neuroectodermal tumor of infancy: A rare case report with differential diagnosis and review of the literature
Assay Type: Competitive Inhibition
Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study